Calgary, Alberta--(Newsfile Corp. - May 21, 2026) - PlasCred Circular Innovations Inc. (CSE: PLAS) (FSE: XV2) ("PlasCred" or the "Company") is pleased to announce that, as a result of strong investor demand, it has closed the second tranche (the "Sec

~ Growing Independent Research Efforts are Expanding Evidence Base Around How PEDMARK® (sodium thiosulfate injection) May Benefit Broader and More Diverse Patient Populations ~ ~ Real-World Evidence Shows Administration of PEDMARK® Approximately Six

The Phase 2b LUMA study of BIIB122 in early-stage Parkinson’s disease did not meet its primary or secondary endpointsBased on data from the Phase 2b LUMA study, Biogen and Denali will discontinue development of BIIB122 in idiopathic Parkinson’s disea

The Phase 2b LUMA study of BIIB122 in early-stage Parkinson’s disease did not meet its primary or secondary endpoints Based on data from the Phase 2b LUMA study, Biogen and Denali will discontinue development of BIIB122 in idiopathic Parkinson’s dise

Manila, Philippines--(Newsfile Corp. - May 21, 2026) - St. Augustine Gold and Copper Limited (TSX: SAU) ("St. Augustine" or the "Company") announces the resignation of Mr. Nicolaos Paraskevas from its board of directors effective May 17, 2026. Mr. Pa

London, United Kingdom--(Newsfile Corp. - May 21, 2026) - Michael J. Thomas, founder of DARWIN™ Works Marketing, has launched the iwon™ podcast (It Wasn't Over Night), a long-form series focused on the reality of building software and technology comp

One new responder observed in the [212Pb]VMT01 3.0 mCi monotherapy cohort for a total of two confirmed responses out of seven (29%) treated in this cohort of the Phase 1/2a study in heavily pre-treated melanoma; further data expected in late 2026[²¹²

Vancouver, British Columbia--(Newsfile Corp. - May 21, 2026) - CanCambria Energy Corp. (TSXV: CCEC) (FSE: 4JH) (OTCQB: CCEYF) ("CanCambria" or the "Company") announced today that it will participate in the 2026 Louisiana Energy Conference hosted by A

In an all-comer PROC population, across multiple dose cohorts, manageable safety profile of the combination was observed with low frequency of high-grade adverse eventsActivity of the combined regimen across all dose cohorts achieved 39% ORR and 7.3-

Montreal, Quebec--(Newsfile Corp. - May 21, 2026) - Amex Exploration Inc. (TSXV: AMX) (FSE: MX0) (OTCQX: AMXEF) ("Amex" or the "Company") is pleased to announce that, further to the Company's news release of earlier today, it has closed its non-broke